ArticlePharmaceuticals (Basel, Switzerland)2026

Integrative In Silico Identification of TP53-Associated Drug Repurposing Candidates in Lung Adenocarcinoma.

Akile Tuncal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.